{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,11]],"date-time":"2026-11-11T01:33:34Z","timestamp":1794360814801,"version":"4.9.0"},"reference-count":138,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2025,4,2]],"date-time":"2025-04-02T00:00:00Z","timestamp":1743552000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,4,2]],"date-time":"2025-04-02T00:00:00Z","timestamp":1743552000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100001711","name":"Schweizerischer Nationalfonds zur F\u00f6rderung der Wissenschaftlichen Forschung","doi-asserted-by":"publisher","award":["310030_192675"],"award-info":[{"award-number":["310030_192675"]}],"id":[{"id":"10.13039\/501100001711","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001711","name":"Schweizerischer Nationalfonds zur F\u00f6rderung der Wissenschaftlichen Forschung","doi-asserted-by":"publisher","award":["310030_192675"],"award-info":[{"award-number":["310030_192675"]}],"id":[{"id":"10.13039\/501100001711","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Leukemia"],"published-print":{"date-parts":[[2025,6]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Acute myeloid leukemia stem cells (LSCs) express major histocompatibility complex (MHC) class I and II and many different immune checkpoint ligands and receptors, in which respect they resemble professional antigen-presenting cells. In addition, LSCs reside in the bone marrow (BM), a primary and secondary lymphoid organ, surrounded by immune cells. The function of these immune checkpoints (ICs) in the regulation of an anti-tumor immune response is well studied and IC inhibitors (ICIs) became a standard of care in many solid tumors. However, ICIs have very limited efficacy in AML. Nevertheless, the expression especially of immune activating ligands and receptors on LSCs is somewhat unexpected, since these cells have to evade protective immunity. Many ICs have been shown to mediate direct signaling in AML blasts and LSCs and thereby regulate self-renewal, differentiation and expansion of leukemic cells. Thus, the expression of ICs on the cell surface or their soluble forms often correlate with worse survival. In this review we summarize recent data on selected ICs of the immunoglobulin superfamily (IgSF) and the tumor necrosis factor receptor superfamily (TNFRSF) that have a documented role in the regulation of LSCs, independent of their immune regulatory role, and might become novel therapeutic targets.<\/jats:p>","DOI":"10.1038\/s41375-025-02566-x","type":"journal-article","created":{"date-parts":[[2025,4,4]],"date-time":"2025-04-04T09:59:08Z","timestamp":1743760748000},"page":"1277-1293","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":31,"title":["Immune checkpoints regulate acute myeloid leukemia stem cells"],"prefix":"10.1038","volume":"39","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6108-0839","authenticated-orcid":false,"given":"Chantal","family":"Reinhardt","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1773-5436","authenticated-orcid":false,"given":"Adrian F.","family":"Ochsenbein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,4,2]]},"reference":[{"key":"2566_CR1","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3390\/cancers12123742","volume":"12","author":"M Arnone","year":"2020","unstructured":"Arnone M, Konantz M, Hanns P, Stanger AMP, Bertels S, Godavarthy PS, et al. Acute Myeloid Leukemia Stem Cells: The Challenges of Phenotypic Heterogeneity. Cancers. 2020;12:1\u201321.","journal-title":"Cancers"},{"key":"2566_CR2","doi-asserted-by":"publisher","first-page":"4656","DOI":"10.1242\/dev.106575","volume":"141","author":"A Nakamura-Ishizu","year":"2014","unstructured":"Nakamura-Ishizu A, Takizawa H, Suda T. The analysis, roles and regulation of quiescence in hematopoietic stem cells. Development. 2014;141:4656\u201366.","journal-title":"Development."},{"key":"2566_CR3","first-page":"1","volume":"8","author":"Y Chen","year":"2022","unstructured":"Chen Y, Li J, Xu L, G\u0103man MA, Zou Z. The genesis and evolution of acute myeloid leukemia stem cells in the microenvironment: From biology to therapeutic targeting. Cell Death. Discovery. 2022;8:1\u201310.","journal-title":"Discovery"},{"key":"2566_CR4","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1038\/cdd.2014.89","volume":"22","author":"C Riether","year":"2015","unstructured":"Riether C, Sch\u00fcrch CM, Ochsenbein AF. Regulation of hematopoietic and leukemic stem cells by the immune system. Cell Death Differ. 2015;22:187.","journal-title":"Cell Death Differ"},{"key":"2566_CR5","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1038\/s41580-019-0103-9","volume":"20","author":"S Pinho","year":"2019","unstructured":"Pinho S, Frenette PS. Haematopoietic stem cell activity and interactions with the niche. Nat Rev Mol Cell Biol. 2019;20:303.","journal-title":"Nat Rev Mol Cell Biol"},{"key":"2566_CR6","doi-asserted-by":"publisher","first-page":"775128","DOI":"10.3389\/fimmu.2021.775128","volume":"12","author":"T Marchand","year":"2021","unstructured":"Marchand T, Pinho S. Leukemic Stem Cells: From Leukemic Niche Biology to Treatment Opportunities. Front Immunol. 2021;12:775128.","journal-title":"Front Immunol"},{"key":"2566_CR7","doi-asserted-by":"crossref","unstructured":"Di Francesco B, Verzella D, Capece D, Vecchiotti D, Di Vito Nolfi M, Flati I, et al. NF-\u03baB: A Druggable Target in Acute Myeloid Leukemia. Cancers. 2022;14:3557.","DOI":"10.3390\/cancers14143557"},{"key":"2566_CR8","doi-asserted-by":"publisher","unstructured":"Radpour R, Simillion C, Wang B, Abbas HA, Riether C, Ochsenbein AF. IL-9 Secreted by Leukemia Stem Cells Induces Th1-Skewed CD4+ T-Cells, which Promote Their Expansion. Blood. 2024. https:\/\/doi.org\/10.1182\/BLOOD.2024024000.","DOI":"10.1182\/BLOOD.2024024000"},{"key":"2566_CR9","doi-asserted-by":"publisher","first-page":"2379","DOI":"10.1038\/s41375-019-0441-9","volume":"33","author":"R Radpour","year":"2019","unstructured":"Radpour R, Riether C, Simillion C, H\u00f6pner S, Bruggmann R, Ochsenbein AF. CD8+ T cells expand stem and progenitor cells in favorable but not adverse risk acute myeloid leukemia. Leukemia. 2019;33:2379\u201392.","journal-title":"Leukemia."},{"key":"2566_CR10","doi-asserted-by":"publisher","first-page":"445","DOI":"10.1016\/j.stem.2018.01.017","volume":"22","author":"Y Hirata","year":"2018","unstructured":"Hirata Y, Furuhashi K, Ishii H, Li HW, Pinho S, Ding L, et al. CD150high bone marrow Tregs maintain hematopoietic stem cell quiescence and immune privilege via adenosine. Cell Stem Cell. 2018;22:445.","journal-title":"Cell Stem Cell"},{"key":"2566_CR11","doi-asserted-by":"publisher","first-page":"468","DOI":"10.1158\/2643-3230.BCD-23-0020","volume":"4","author":"A Nelde","year":"2023","unstructured":"Nelde A, Schuster H, Heitmann JS, Bauer J, Maringer Y, Zwick M, et al. Immune Surveillance of Acute Myeloid Leukemia Is Mediated by HLA-Presented Antigens on Leukemia Progenitor Cells. Blood Cancer Discov. 2023;4:468\u201389.","journal-title":"Blood Cancer Discov"},{"key":"2566_CR12","doi-asserted-by":"publisher","first-page":"6723","DOI":"10.3389\/fimmu.2022.1049301","volume":"13","author":"C Riether","year":"2022","unstructured":"Riether C. Regulation of hematopoietic and leukemia stem cells by regulatory T cells. Front Immunol. 2022;13:6723.","journal-title":"Front Immunol"},{"key":"2566_CR13","doi-asserted-by":"crossref","unstructured":"Zhang Y, Zheng J. Functions of immune checkpoint molecules beyond immune evasion. In: Xu J, editor. Regulation of cancer immune checkpoints. Advances in experimental medicine and biology. Singapore: Springer; 2020. p. 201\u201326.","DOI":"10.1007\/978-981-15-3266-5_9"},{"key":"2566_CR14","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1038\/nri3405","volume":"13","author":"L Chen","year":"2013","unstructured":"Chen L, Flies DB. Molecular mechanisms of T cell co-stimulation and co-inhibition. Nat Rev Immunol. 2013;13:227\u201342.","journal-title":"Nat Rev Immunol"},{"key":"2566_CR15","doi-asserted-by":"publisher","first-page":"780","DOI":"10.1002\/eji.201746984","volume":"47","author":"D Farr\u00e9","year":"2017","unstructured":"Farr\u00e9 D, Mart\u00ednez-Vicente P, Engel P, Angulo A. Immunoglobulin superfamily members encoded by viruses and their multiple roles in immune evasion. Eur J Immunol. 2017;47:780\u201396.","journal-title":"Eur J Immunol"},{"key":"2566_CR16","doi-asserted-by":"publisher","first-page":"766","DOI":"10.1016\/j.str.2013.02.022","volume":"21","author":"R Rubinstein","year":"2013","unstructured":"Rubinstein R, Ramagopal UA, Nathenson SG, Almo SC, Fiser A. Functional classification of immune regulatory proteins. Structure 2013;21:766\u201376.","journal-title":"Structure"},{"key":"2566_CR17","doi-asserted-by":"crossref","unstructured":"Baldanzi G. Immune Checkpoint Receptors Signaling in T Cells. Int J Mol Sci. 2022;23:3529.","DOI":"10.3390\/ijms23073529"},{"key":"2566_CR18","doi-asserted-by":"publisher","first-page":"631","DOI":"10.1016\/j.molimm.2004.04.010","volume":"41","author":"CA Lowell","year":"2004","unstructured":"Lowell CA. Src-family kinases: rheostats of immune cell signaling. Mol Immunol. 2004;41:631\u201343.","journal-title":"Mol Immunol"},{"key":"2566_CR19","doi-asserted-by":"crossref","unstructured":"Vanamee \u00c9S, Faustman DL. Structural principles of tumor necrosis factor superfamily signaling. Sci Signal. 2018;11:eaao4910.","DOI":"10.1126\/scisignal.aao4910"},{"key":"2566_CR20","doi-asserted-by":"publisher","first-page":"1131","DOI":"10.1111\/febs.13968","volume":"284","author":"D Siegmund","year":"2017","unstructured":"Siegmund D, Lang I, Wajant H. Cell death\u2010independent activities of the death receptors CD95, TRAILR1, and TRAILR2. FEBS J. 2017;284:1131\u201359.","journal-title":"FEBS J"},{"key":"2566_CR21","doi-asserted-by":"crossref","unstructured":"Park HH. Structure of TRAF Family: Current Understanding of Receptor Recognition. Front Immunol. 2018;9:1999.","DOI":"10.3389\/fimmu.2018.01999"},{"key":"2566_CR22","doi-asserted-by":"publisher","first-page":"2186","DOI":"10.1038\/leu.2012.145","volume":"26","author":"S Anguille","year":"2012","unstructured":"Anguille S, Van Tendeloo VF, Berneman ZN. Leukemia-associated antigens and their relevance to the immunotherapy of acute myeloid leukemia. Leukemia. 2012;26:2186\u201396.","journal-title":"Leukemia"},{"key":"2566_CR23","doi-asserted-by":"publisher","first-page":"2249","DOI":"10.3390\/cells11142249","volume":"11","author":"Y Abaza","year":"2022","unstructured":"Abaza Y, Zeidan AM. Immune Checkpoint Inhibition in Acute Myeloid Leukemia and Myelodysplastic Syndromes. Cells. 2022;11:2249.","journal-title":"Cells"},{"key":"2566_CR24","doi-asserted-by":"publisher","first-page":"1108200","DOI":"10.3389\/fimmu.2023.1108200","volume":"14","author":"B Aru","year":"2023","unstructured":"Aru B, Pehlivano\u011flu C, Dal Z, Dereli-\u00c7al\u0131\u015fkan NN, G\u00fcrl\u00fc E, Yan\u0131kkaya-Demirel G. A potential area of use for immune checkpoint inhibitors: Targeting bone marrow microenvironment in acute myeloid leukemia. Front Immunol. 2023;14:1108200.","journal-title":"Front Immunol"},{"key":"2566_CR25","doi-asserted-by":"publisher","first-page":"15907","DOI":"10.3390\/ijms232415907","volume":"23","author":"S Maurer","year":"2022","unstructured":"Maurer S, Zhong X, Prada BD, Mascarenhas J, de Andrade LF. The Latest Breakthroughs in Immunotherapy for Acute Myeloid Leukemia, with a Special Focus on NKG2D Ligands. Int J Mol Sci. 2022;23:15907.","journal-title":"Int J Mol Sci"},{"key":"2566_CR26","doi-asserted-by":"crossref","unstructured":"Radpour R, Stucki M, Riether C, Ochsenbein AF. Epigenetic silencing of immune-checkpoint receptors in bone marrow-infiltrating T cells in acute myeloid leukemia. Front Oncol. 2021;11:663406.","DOI":"10.3389\/fonc.2021.663406"},{"key":"2566_CR27","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1038\/ni1443","volume":"8","author":"AH Sharpe","year":"2007","unstructured":"Sharpe AH, Wherry EJ, Ahmed R, Freeman GJ. The function of programmed cell death 1 and its ligands in regulating autoimmunity and infection. Nat Immunol. 2007;8:239\u201345.","journal-title":"Nat Immunol"},{"key":"2566_CR28","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1038\/nri.2017.108","volume":"18","author":"AH Sharpe","year":"2017","unstructured":"Sharpe AH, Pauken KE. The diverse functions of the PD1 inhibitory pathway. Nat Rev Immunol. 2017;18:153\u201367.","journal-title":"Nat Rev Immunol"},{"key":"2566_CR29","doi-asserted-by":"publisher","first-page":"22","DOI":"10.3389\/fcell.2021.767466","volume":"9","author":"MJ Kim","year":"2021","unstructured":"Kim MJ, Ha SJ. Differential Role of PD-1 Expressed by Various Immune and Tumor Cells in the Tumor Immune Microenvironment: Expression, Function, Therapeutic Efficacy, and Resistance to Cancer Immunotherapy. Front Cell Dev Biol. 2021;9:22.","journal-title":"Front Cell Dev Biol"},{"key":"2566_CR30","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1038\/s41590-022-01385-x","volume":"24","author":"A Christofides","year":"2023","unstructured":"Christofides A, Katopodi XL, Cao C, Karagkouni D, Aliazis K, Yenyuwadee S, et al. SHP-2 and PD-1-SHP-2 signaling regulate myeloid cell differentiation and antitumor responses. Nat Immunol. 2023;24:55.","journal-title":"Nat Immunol"},{"key":"2566_CR31","doi-asserted-by":"publisher","first-page":"115514","DOI":"10.1016\/j.biopha.2023.115514","volume":"167","author":"M Chen","year":"2023","unstructured":"Chen M, Bie L, Ying J. Cancer cell-intrinsic PD-1: Its role in malignant progression and immunotherapy. Biomed Pharmacother. 2023;167:115514.","journal-title":"Biomed Pharmacother"},{"key":"2566_CR32","doi-asserted-by":"publisher","first-page":"568931","DOI":"10.3389\/fimmu.2020.568931","volume":"11","author":"K Hudson","year":"2020","unstructured":"Hudson K, Cross N, Jordan-Mahy N, Leyland R. The Extrinsic and Intrinsic Roles of PD-L1 and Its Receptor PD-1: Implications for Immunotherapy Treatment. Front Immunol. 2020;11:568931.","journal-title":"Front Immunol"},{"key":"2566_CR33","doi-asserted-by":"publisher","first-page":"1280","DOI":"10.1038\/leu.2013.355","volume":"28","author":"H Yang","year":"2013","unstructured":"Yang H, Bueso-Ramos C, Dinardo C, Estecio MR, Davanlou M, Geng QR, et al. Expression of PD-L1, PD-L2, PD-1 and CTLA4 in myelodysplastic syndromes is enhanced by treatment with hypomethylating agents. Leukemia. 2013;28:1280\u20138.","journal-title":"Leukemia"},{"key":"2566_CR34","doi-asserted-by":"crossref","unstructured":"Suo S, Nguyen LXT, Li F, Zhao D, Qiao J, Liang C, et al. Acute Myeloid Leukemia Cell-Intrinsic PD-1 Functions Promoting Leukemia Development By Recruiting SHP2. Blood. 2021;138:1173.","DOI":"10.1182\/blood-2021-154467"},{"key":"2566_CR35","doi-asserted-by":"crossref","unstructured":"Romano F, Giannone AG, Siragusa S, Porcasi R, Florena AM. Immunoistochemical Expression of PD-1 and PD-L1 in Bone Marrow Biopsies of Patients with Acute Myeloid Leukemia. Hematol Rep. 2020;12:8211.","DOI":"10.4081\/hr.2020.8211"},{"key":"2566_CR36","doi-asserted-by":"publisher","first-page":"517","DOI":"10.1111\/ejh.12762","volume":"97","author":"JU Schmohl","year":"2016","unstructured":"Schmohl JU, Nuebling T, Wild J, Kroell T, Kanz L, Salih HR, et al. Expression of RANK-L and in part of PD-1 on blasts in patients with acute myeloid leukemia correlates with prognosis. Eur J Haematol. 2016;97:517\u201327.","journal-title":"Eur J Haematol"},{"key":"2566_CR37","doi-asserted-by":"publisher","first-page":"400","DOI":"10.1016\/j.immuni.2011.06.015","volume":"35","author":"B Youngblood","year":"2011","unstructured":"Youngblood B, Oestreich KJ, Ha SJ, Duraiswamy J, Akondy RS, West EE, et al. Chronic virus infection enforces demethylation of the locus that encodes PD-1 in antigen-specific CD8+ T cells. Immunity. 2011;35:400.","journal-title":"Immunity."},{"key":"2566_CR38","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1136\/jclinpath-2017-204853","volume":"71","author":"A Kythreotou","year":"2018","unstructured":"Kythreotou A, Siddique A, Mauri FA, Bower M, Pinato DJ. PD-L1. J Clin Pathol. 2018;71:189\u201394.","journal-title":"J Clin Pathol"},{"key":"2566_CR39","doi-asserted-by":"crossref","unstructured":"Escors D, Gato-Ca\u00f1as M, Zuazo M, Arasanz H, Garc\u00eda-Granda MJ, Vera R, et al. The intracellular signalosome of PD-L1 in cancer cells. Sig Transduct Target Ther. 2018;3:26.","DOI":"10.1038\/s41392-018-0022-9"},{"key":"2566_CR40","doi-asserted-by":"crossref","unstructured":"Dong P, Xiong Y, Yue J, Hanley SJB, Watari H. Tumor-intrinsic PD-L1 signaling in cancer initiation, development and treatment: Beyond immune evasion. Front Oncol. 2018;8:386.","DOI":"10.3389\/fonc.2018.00386"},{"key":"2566_CR41","doi-asserted-by":"publisher","first-page":"1839","DOI":"10.1007\/s00262-010-0909-y","volume":"59","author":"C Berthon","year":"2010","unstructured":"Berthon C, Driss V, Liu J, Kuranda K, Leleu X, Jouy N, et al. In acute myeloid leukemia, B7-H1 (PD-L1) protection of blasts from cytotoxic T cells is induced by TLR ligands and interferon-gamma and can be reversed using MEK inhibitors. Cancer Immunol Immunother. 2010;59:1839.","journal-title":"Cancer Immunol Immunother"},{"key":"2566_CR42","doi-asserted-by":"publisher","first-page":"e499","DOI":"10.3324\/haematol.2017.176461","volume":"102","author":"J Greiner","year":"2017","unstructured":"Greiner J, Hofmann S, Schmitt M, G\u00f6tz M, Wiesneth M, Schrezenmeier H, et al. Acute myeloid leukemia with mutated nucleophosmin 1: an immunogenic acute myeloid leukemia subtype and potential candidate for immune checkpoint inhibition. Haematologica. 2017;102:e499.","journal-title":"Haematologica."},{"key":"2566_CR43","doi-asserted-by":"publisher","first-page":"1441","DOI":"10.1007\/s00277-017-3051-5","volume":"96","author":"F Haroun","year":"2017","unstructured":"Haroun F, Solola SA, Nassereddine S, Tabbara I. PD-1 signaling and inhibition in AML and MDS. Ann Hematol. 2017;96:1441\u20138.","journal-title":"Ann Hematol"},{"key":"2566_CR44","doi-asserted-by":"crossref","unstructured":"Valent P, Sadovnik I, Eisenwort G, Bauer K, Herrmann H, Gleixner KV, et al. Immunotherapy-Based Targeting and Elimination of Leukemic Stem Cells in AML and CML. Int J Mol Sci. 2019;20:4233.","DOI":"10.3390\/ijms20174233"},{"key":"2566_CR45","doi-asserted-by":"publisher","first-page":"5531","DOI":"10.21873\/anticanres.13746","volume":"39","author":"SH Kang","year":"2019","unstructured":"Kang SH, Hwang HJ, Yoo JW, Kim H, Choi ES, Hwang SH, et al. Expression of Immune Checkpoint Receptors on T-Cells and Their Ligands on Leukemia Blasts in Childhood Acute Leukemia. Anticancer Res. 2019;39:5531\u20139.","journal-title":"Anticancer Res"},{"key":"2566_CR46","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41598-021-99269-x","volume":"12","author":"F Wang","year":"2022","unstructured":"Wang F, Yang L, Xiao M, Zhang Z, Shen J, Anuchapreeda S, et al. PD-L1 regulates cell proliferation and apoptosis in acute myeloid leukemia by activating PI3K-AKT signaling pathway. Sci Rep. 2022;12:1\u201312.","journal-title":"Sci Rep"},{"key":"2566_CR47","first-page":"999","volume":"43","author":"P Ma","year":"2020","unstructured":"Ma P, Xing M, Han L, Gan S, Ma J, Wu F, et al. High PD-L1 expression drives glycolysis via an Akt\/mTOR\/HIF-1\u03b1 axis in acute myeloid leukemia. Oncol Rep. 2020;43:999\u20131009.","journal-title":"Oncol Rep"},{"key":"2566_CR48","doi-asserted-by":"crossref","unstructured":"Chen C, Liang C, Wang S, Chio CL, Zhang Y, Zeng C, et al. Expression patterns of immune checkpoints in acute myeloid leukemia. J Hematol Oncol. 2020;13:28.","DOI":"10.1186\/s13045-020-00853-x"},{"key":"2566_CR49","doi-asserted-by":"crossref","unstructured":"Lu C, Paschall AV, Shi H, Savage N, Waller JL, Sabbatini ME, et al. The MLL1-H3K4me3 Axis-Mediated PD-L1 Expression and Pancreatic Cancer Immune Evasion. J Natl Cancer Inst. 2017;109:djw283.","DOI":"10.1093\/jnci\/djw283"},{"key":"2566_CR50","doi-asserted-by":"publisher","first-page":"2780","DOI":"10.1038\/leu.2017.163","volume":"31","author":"AR Pyzer","year":"2017","unstructured":"Pyzer AR, Stroopinsky D, Rosenblatt J, Anastasiadou E, Rajabi H, Washington A, et al. MUC1 inhibition leads to decrease in PD-L1 levels via upregulation of miRNAs. Leukemia. 2017;31:2780\u201390.","journal-title":"Leukemia"},{"key":"2566_CR51","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41598-019-48256-4","volume":"9","author":"D Yoyen-Ermis","year":"2019","unstructured":"Yoyen-Ermis D, Tunali G, Tavukcuoglu E, Horzum U, Ozkazanc D, Sutlu T, et al. Myeloid maturation potentiates STAT3-mediated atypical IFN-\u03b3 signaling and upregulation of PD-1 ligands in AML and MDS. Sci Rep. 2019;9:1\u201311. 2019 9:1","journal-title":"Sci Rep"},{"key":"2566_CR52","doi-asserted-by":"publisher","first-page":"1066","DOI":"10.1182\/blood.2021012519","volume":"139","author":"X You","year":"2022","unstructured":"You X, Liu F, Binder M, Vedder A, Lasho T, Wen Z, et al. Asxl1 loss cooperates with oncogenic Nras in mice to reprogram the immune microenvironment and drive leukemic transformation. Blood. 2022;139:1066.","journal-title":"Blood."},{"key":"2566_CR53","first-page":"2543","volume":"17","author":"H Liu","year":"2019","unstructured":"Liu H, Hu Y, Rimoldi R, Von Hagt C, Khong EWC, Lee N, et al. Epigenetic treatment-mediated modulation of PD-L1 predicts potential therapy resistance over response markers in myeloid malignancies: A molecular mechanism involving effectors of PD-L1 reverse signaling. Oncol Lett. 2019;17:2543\u201350.","journal-title":"Oncol Lett"},{"key":"2566_CR54","first-page":"495","volume":"22","author":"M Soltani","year":"2023","unstructured":"Soltani M, Vosoughi M, Ganjalikhani-Hakemi M, Shapoorian H, Beshkar P, Eskandari N, et al. PD-1\/PD-L1 Interaction Regulates BCL2, KI67, BAX, and CASP3, Altering Proliferation, Survival, and Apoptosis in Acute Myeloid Leukemia. Iran J Allergy Asthma Immunol. 2023;22:495\u2013503.","journal-title":"Iran J Allergy Asthma Immunol"},{"key":"2566_CR55","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12885-023-10947-7","volume":"23","author":"M Soltani","year":"2023","unstructured":"Soltani M, Ghanadian M, Ghezelbash B, Shokouhi A, Zamyatnin AA, Bazhin AV, et al. PD-L1 stimulation can promote proliferation and survival of leukemic cells by influencing glucose and fatty acid metabolism in acute myeloid leukemia. BMC Cancer. 2023;23:1\u20139.","journal-title":"BMC Cancer"},{"key":"2566_CR56","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13045-016-0350-6","volume":"9","author":"X Fang","year":"2016","unstructured":"Fang X, Chen C, Xia F, Yu Z, Zhang Y, Zhang F, et al. CD274 promotes cell cycle entry of leukemia-initiating cells through JNK\/Cyclin D2 signaling. J Hematol Oncol. 2016;9:1\u201311.","journal-title":"J Hematol Oncol"},{"key":"2566_CR57","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1007\/978-981-15-3266-5_2","volume":"1248","author":"S Van Coillie","year":"2020","unstructured":"Van Coillie S, Wiernicki B, Xu J. Molecular and Cellular Functions of CTLA-4. Adv Exp Med Biol. 2020;1248:7\u201332.","journal-title":"Adv Exp Med Biol"},{"key":"2566_CR58","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1182\/blood-2002-06-1668","volume":"101","author":"MP Pistillo","year":"2003","unstructured":"Pistillo MP, Tazzari PL, Palmisano GL, Pierri I, Bolognesi A, Ferlito F, et al. CTLA-4 is not restricted to the lymphoid cell lineage and can function as a target molecule for apoptosis induction of leukemic cells. Blood 2003;101:202\u20139.","journal-title":"Blood"},{"key":"2566_CR59","first-page":"6163","volume":"16","author":"B Zhang","year":"2018","unstructured":"Zhang B, Dang J, Ba D, Wang C, Han J, Zheng F. Potential function of CTLA-4 in the tumourigenic capacity of melanoma stem cells. Oncol Lett. 2018;16:6163\u201370.","journal-title":"Oncol Lett"},{"key":"2566_CR60","doi-asserted-by":"publisher","first-page":"260","DOI":"10.1159\/000492876","volume":"49","author":"B Wang","year":"2018","unstructured":"Wang B, Qin L, Ren M, Sun H. Effects of Combination of Anti-CTLA-4 and Anti-PD-1 on Gastric Cancer Cells Proliferation, Apoptosis and Metastasis. Cell Physiol Biochem. 2018;49:260\u201370.","journal-title":"Cell Physiol Biochem"},{"key":"2566_CR61","doi-asserted-by":"publisher","first-page":"679","DOI":"10.1007\/s12026-023-09378-0","volume":"71","author":"P Azimnasab-sorkhabi","year":"2023","unstructured":"Azimnasab-sorkhabi P, Soltani-asl M, Yoshinaga TT, Massoco C, de O. Kfoury Junior JR. IDO blockade negatively regulates the CTLA-4 signaling in breast cancer cells. Immunol Res. 2023;71:679\u201386.","journal-title":"Immunol Res"},{"key":"2566_CR62","doi-asserted-by":"publisher","first-page":"538","DOI":"10.1002\/ijc.21155","volume":"117","author":"E Contardi","year":"2005","unstructured":"Contardi E, Palmisano GL, Tazzari PL, Martelli AM, Fal\u00e0 F, Fabbi M, et al. CTLA-4 is constitutively expressed on tumor cells and can trigger apoptosis upon ligand interaction. Int J Cancer. 2005;117:538\u201350.","journal-title":"Int J Cancer"},{"key":"2566_CR63","doi-asserted-by":"publisher","first-page":"597","DOI":"10.1111\/j.1365-2141.2006.06472.x","volume":"136","author":"S Laurent","year":"2007","unstructured":"Laurent S, Palmisano GL, Martelli AM, Kato T, Tazzari PL, Pierri I, et al. CTLA-4 expressed by chemoresistant, as well as untreated, myeloid leukaemia cells can be targeted with ligands to induce apoptosis. Br J Haematol. 2007;136:597\u2013608.","journal-title":"Br J Haematol"},{"key":"2566_CR64","first-page":"84","volume":"10","author":"M Ramzi","year":"2019","unstructured":"Ramzi M, Saadi MI, Yaghobi R, Arandi N. Dysregulated Expression of CD28 and CTLA-4 Molecules in Patients with Acute Myeloid Leukemia and Possible Association with Development of Graft versus Host Disease after Hematopoietic Stem Cell Transplantation. Int J Organ Transpl Med. 2019;10:84.","journal-title":"Int J Organ Transpl Med"},{"key":"2566_CR65","doi-asserted-by":"publisher","first-page":"486","DOI":"10.1038\/leu.2008.339","volume":"23","author":"A P\u00e9rez-Garc\u00eda","year":"2008","unstructured":"P\u00e9rez-Garc\u00eda A, Brunet S, Berlanga JJ, Tormo M, Nomdedeu J, Guardia R, et al. CTLA-4 genotype and relapse incidence in patients with acute myeloid leukemia in first complete remission after induction chemotherapy. Leukemia. 2008;23:486\u201391.","journal-title":"Leukemia"},{"key":"2566_CR66","doi-asserted-by":"publisher","first-page":"973","DOI":"10.1016\/j.immuni.2016.04.020","volume":"44","author":"JH Esensten","year":"2016","unstructured":"Esensten JH, Helou YA, Chopra G, Weiss A, Bluestone JA. CD28 Costimulation: From Mechanism to Therapy. Immunity 2016;44:973\u201388.","journal-title":"Immunity"},{"key":"2566_CR67","doi-asserted-by":"publisher","first-page":"7766","DOI":"10.1074\/jbc.M105902200","volume":"277","author":"S Suvas","year":"2002","unstructured":"Suvas S, Singh V, Sahdev S, Vohra H, Agrewala JN. Distinct Role of CD80 and CD86 in the Regulation of the Activation of B Cell and B Cell Lymphoma. J Biol Chem. 2002;277:7766\u201375.","journal-title":"J Biol Chem"},{"key":"2566_CR68","doi-asserted-by":"publisher","first-page":"1257","DOI":"10.1046\/j.1365-2141.1998.00901.x","volume":"102","author":"A Maeda","year":"1998","unstructured":"Maeda A, Yamamoto K, Yamashita K, Asagoe K, Nohgawa M, Kita K, et al. The expression of co-stimulatory molecules and their relation- ship to the prognosis of human acute myeloid leukaemia: poor prognosis of B7-2-positive leukaemia. Br J Haematol. 1998;102:1257\u201362.","journal-title":"Br J Haematol"},{"key":"2566_CR69","doi-asserted-by":"publisher","first-page":"5708","DOI":"10.1158\/1078-0432.CCR-04-2672","volume":"11","author":"H Tamura","year":"2005","unstructured":"Tamura H, Dan K, Tamada K, Nakamura K, Shioi Y, Hyodo H, et al. Expression of Functional B7-H2 and B7.2 Costimulatory Molecules and Their Prognostic Implications in De novo Acute Myeloid Leukemia. Clin Cancer Res. 2005;11:5708\u201317.","journal-title":"Clin Cancer Res"},{"key":"2566_CR70","doi-asserted-by":"publisher","first-page":"152049","DOI":"10.1016\/j.imbio.2020.152049","volume":"226","author":"I Antohe","year":"2021","unstructured":"Antohe I, Tanasa MP, D\u0103sc\u0103lescu A, D\u0103n\u0103il\u0103 C, Titieanu A, Zlei M, et al. The MHC-II antigen presentation machinery and B7 checkpoint ligands display distinctive patterns correlated with acute myeloid leukaemias blast cells HLA-DR expression. Immunobiology 2021;226:152049.","journal-title":"Immunobiology"},{"key":"2566_CR71","doi-asserted-by":"publisher","first-page":"1223","DOI":"10.1038\/sj.leu.2403391","volume":"18","author":"R Vereecque","year":"2004","unstructured":"Vereecque R, Saudemont A, Quesnel B. Cytosine arabinoside induces costimulatory molecule expression in acute myeloid leukemia cells. Leukemia. 2004;18:1223\u201330.","journal-title":"Leukemia"},{"key":"2566_CR72","doi-asserted-by":"publisher","first-page":"3847","DOI":"10.1182\/blood.V96.12.3847","volume":"96","author":"T Maeda","year":"2000","unstructured":"Maeda T, Towatari M, Kosugi H, Saito H. Up-regulation of costimulatory\/adhesion molecules by histone deacetylase inhibitors in acute myeloid leukemia cells. Blood 2000;96:3847\u201356.","journal-title":"Blood"},{"key":"2566_CR73","doi-asserted-by":"publisher","first-page":"85085","DOI":"10.18632\/oncotarget.18564","volume":"8","author":"J Fang","year":"2017","unstructured":"Fang J, Ying H, Mao T, Fang Y, Lu Y, Wang H, et al. Upregulation of CD11b and CD86 through LSD1 inhibition promotes myeloid differentiation and suppresses cell proliferation in human monocytic leukemia cells. Oncotarget 2017;8:85085.","journal-title":"Oncotarget"},{"key":"2566_CR74","doi-asserted-by":"crossref","unstructured":"Zhang Q, Ma R, Chen H, Guo W, Li Z, Xu K, et al. CD86 Is Associated with Immune Infiltration and Immunotherapy Signatures in AML and Promotes Its Progression. J Oncol. 2023;2023:9988405.","DOI":"10.1155\/2023\/9988405"},{"key":"2566_CR75","doi-asserted-by":"publisher","first-page":"819","DOI":"10.1046\/j.1365-2141.2003.04684.x","volume":"123","author":"GA Banat","year":"2003","unstructured":"Banat GA, Ihlow K, Usluoglu N, Hoppmann S, Hoeck M, Pralle H. Core-binding factor-\u03b2 positive acute myeloid leukaemia cells induce T-cell responses. Br J Haematol. 2003;123:819\u201329.","journal-title":"Br J Haematol"},{"key":"2566_CR76","doi-asserted-by":"publisher","first-page":"7831","DOI":"10.1002\/cam4.4284","volume":"10","author":"LY Zhang","year":"2021","unstructured":"Zhang LY, Jin Y, Xia PH, Lin J, Ma JC, Li T, et al. Integrated analysis reveals distinct molecular, clinical, and immunological features of B7\u2010H3 in acute myeloid leukemia. Cancer Med. 2021;10:7831.","journal-title":"Cancer Med"},{"key":"2566_CR77","doi-asserted-by":"crossref","unstructured":"Nygren MK, Tekle C, Ingebrigtsen VA, Fodstad O B7-H3 and its relevance in cancer; Immunological and non-immunological perspectives. Front Biosci. 2011;3E:989\u201393.","DOI":"10.2741\/e304"},{"key":"2566_CR78","doi-asserted-by":"publisher","first-page":"1117","DOI":"10.1038\/s41374-019-0238-5","volume":"99","author":"J Zhang","year":"2019","unstructured":"Zhang J, Wang J, Marzese DM, Wang X, Yang Z, Li C, et al. B7H3 regulates differentiation and serves as a potential biomarker and theranostic target for human glioblastoma. Lab Investig. 2019;99:1117\u201329.","journal-title":"Lab Investig"},{"key":"2566_CR79","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1179\/1607845414Y.0000000186","volume":"20","author":"Y Hu","year":"2015","unstructured":"Hu Y, Lv X, Wu Y, Xu J, Wang L, Chen W, et al. Expression of costimulatory molecule B7-H3 and its prognostic implications in human acute leukemia. Hematology 2015;20:187\u201395.","journal-title":"Hematology"},{"key":"2566_CR80","doi-asserted-by":"publisher","first-page":"1879","DOI":"10.1002\/cam4.522","volume":"4","author":"T Guery","year":"2015","unstructured":"Guery T, Roumier C, Berthon C, Renneville A, Preudhomme C, Quesnel B. B7\u2010H3 protein expression in acute myeloid leukemia. Cancer Med. 2015;4:1879.","journal-title":"Cancer Med"},{"key":"2566_CR81","doi-asserted-by":"publisher","first-page":"11987","DOI":"10.1080\/21655979.2021.2001182","volume":"12","author":"W Zhang","year":"2021","unstructured":"Zhang W, Zhang L, Qian J, Lin J, Chen Q, Yuan Q, et al. Expression characteristic of 4Ig B7-H3 and 2Ig B7-H3 in acute myeloid leukemia. Bioengineered. 2021;12:11987\u20132002.","journal-title":"Bioengineered"},{"key":"2566_CR82","doi-asserted-by":"publisher","first-page":"1721","DOI":"10.2147\/OTT.S85272","volume":"8","author":"W Zhang","year":"2015","unstructured":"Zhang W, Wang J, Wang Y, Dong F, Zhu M, Wan W, et al. B7-H3 silencing by RNAi inhibits tumor progression and enhances chemosensitivity in U937 cells. Onco Targets Ther. 2015;8:1721.","journal-title":"Onco Targets Ther"},{"key":"2566_CR83","doi-asserted-by":"publisher","first-page":"883","DOI":"10.1016\/j.tips.2019.09.008","volume":"40","author":"P John","year":"2019","unstructured":"John P, Wei Y, Liu W, Du M, Guan F, Zang X. The B7x Immune Checkpoint Pathway: From Discovery to Clinical Trial. Trends Pharm Sci. 2019;40:883\u201396.","journal-title":"Trends Pharm Sci"},{"key":"2566_CR84","doi-asserted-by":"publisher","first-page":"5347","DOI":"10.1038\/onc.2012.600","volume":"32","author":"L Zhang","year":"2013","unstructured":"Zhang L, Wu H, Lu D, Li G, Sun C, Song H, et al. The costimulatory molecule B7-H4 promote tumor progression and cell proliferation through translocating into nucleus. Oncogene. 2013;32:5347\u201358.","journal-title":"Oncogene"},{"key":"2566_CR85","doi-asserted-by":"publisher","first-page":"153323","DOI":"10.1016\/j.prp.2020.153323","volume":"218","author":"Y Feng","year":"2021","unstructured":"Feng Y, Yang Z, Zhang C, Che N, Liu X, Xuan Y. B7-H4 induces epithelial\u2013mesenchymal transition and promotes colorectal cancer stemness. Pathol Res Pr. 2021;218:153323.","journal-title":"Pathol Res Pr"},{"key":"2566_CR86","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1016\/j.humpath.2018.05.021","volume":"80","author":"L Piao","year":"2018","unstructured":"Piao L, Yang Z, Jin J, Ni W, Qi W, Xuan Y. B7H4 is associated with stemness and cancer progression in esophageal squamous cell carcinoma. Hum Pathol. 2018;80:152\u201362.","journal-title":"Hum Pathol"},{"key":"2566_CR87","doi-asserted-by":"publisher","first-page":"2260","DOI":"10.1038\/leu.2017.232","volume":"31","author":"F Xia","year":"2017","unstructured":"Xia F, Zhang Y, Xie L, Jiang H, Zeng H, Chen C, et al. B7-H4 enhances the differentiation of murine leukemia-initiating cells via the PTEN\/AKT\/RCOR2\/RUNX1 pathways. Leukemia. 2017;31:2260\u20134.","journal-title":"Leukemia"},{"key":"2566_CR88","doi-asserted-by":"publisher","first-page":"707","DOI":"10.3324\/haematol.2016.151555","volume":"102","author":"F Zhang","year":"2017","unstructured":"Zhang F, Liu X, Chen C, Zhu J, Yu Z, Xie J, et al. CD244 maintains the proliferation ability of leukemia initiating cells through SHP-2\/p27kip1 signaling. Haematologica. 2017;102:707\u201318.","journal-title":"Haematologica."},{"key":"2566_CR89","doi-asserted-by":"crossref","unstructured":"Kim TK, Han X, Hu Q, Vandsemb EN, Fielder CM, Hong J, et al. PD-1H\/VISTA mediates immune evasion in acute myeloid leukemia. J Clin Invest. 2024;134:e164325.","DOI":"10.1172\/JCI164325"},{"key":"2566_CR90","doi-asserted-by":"crossref","unstructured":"Yasinska IM, Meyer NH, Schlichtner S, Hussain R, Siligardi G, Casely-Hayford M, et al. Ligand-Receptor Interactions of Galectin-9 and VISTA Suppress Human T Lymphocyte Cytotoxic Activity. Front Immunol. 2020;11:580557.","DOI":"10.3389\/fimmu.2020.580557"},{"key":"2566_CR91","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1136\/gutjnl-2018-318070","volume":"69","author":"R Wang","year":"2020","unstructured":"Wang R, Song S, Harada K, Ghazanfari Amlashi F, Badgwell B, Pizzi MP, et al. Original article: Multiplex profiling of peritoneal metastases from gastric adenocarcinoma identified novel targets and molecular subtypes that predict treatment response. Gut 2020;69:18.","journal-title":"Gut"},{"key":"2566_CR92","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13045-023-01410-y","volume":"16","author":"J Mo","year":"2023","unstructured":"Mo J, Deng L, Peng K, Ouyang S, Ding W, Lou L, et al. Targeting STAT3-VISTA axis to suppress tumor aggression and burden in acute myeloid leukemia. J Hematol Oncol. 2023;16:1\u20136.","journal-title":"J Hematol Oncol"},{"key":"2566_CR93","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1016\/j.stem.2015.07.011","volume":"17","author":"Y Kikushige","year":"2015","unstructured":"Kikushige Y, Miyamoto T, Yuda J, Jabbarzadeh-Tabrizi S, Shima T, Takayanagi SI, et al. A TIM-3\/Gal-9 Autocrine Stimulatory Loop Drives Self-Renewal of Human Myeloid Leukemia Stem Cells and Leukemic Progression. Cell Stem Cell. 2015;17:341\u201352.","journal-title":"Cell Stem Cell"},{"key":"2566_CR94","doi-asserted-by":"publisher","first-page":"5965","DOI":"10.1182\/blood-2023-186927","volume":"142","author":"T Guillaudeux","year":"2023","unstructured":"Guillaudeux T, Sridhar S, Frazier E, Ovechkina Y, Iadonato S. VISTA a Potential New Immuno-Oncology Target in Acute Myeloid Leukemia. Blood. 2023;142:5965.","journal-title":"Blood."},{"key":"2566_CR95","doi-asserted-by":"publisher","first-page":"1577","DOI":"10.1177\/1535370219855970","volume":"244","author":"SM West","year":"2019","unstructured":"West SM, Deng XA. Considering B7-CD28 as a family through sequence and structure. Exp Biol Med. 2019;244:1577.","journal-title":"Exp Biol Med"},{"key":"2566_CR96","doi-asserted-by":"crossref","unstructured":"Ying H, Xu J, Zhang X, Liang T, Bai X. Human endogenous retrovirus-H long terminal repeat-associating 2: The next immune checkpoint for antitumour therapy. EBioMedicine. 2022;79:103987.","DOI":"10.1016\/j.ebiom.2022.103987"},{"key":"2566_CR97","first-page":"1","volume":"15","author":"H Wang","year":"2024","unstructured":"Wang H, Sica RA, Kaur G, Galbo PM, Jing Z, Nishimura CD, et al. TMIGD2 is an orchestrator and therapeutic target on human acute myeloid leukemia stem cells. Nat Commun. 2024;15:1\u201317.","journal-title":"Nat Commun"},{"key":"2566_CR98","doi-asserted-by":"publisher","first-page":"e378","DOI":"10.1038\/oncsis.2017.77","volume":"6","author":"N Woolf","year":"2017","unstructured":"Woolf N, Pearson BE, Bondzie PA, Meyer RD, Lavaei M, Belkina AC, et al. Targeting tumor multicellular aggregation through IGPR-1 inhibits colon cancer growth and improves chemotherapy. Oncogenesis. 2017;6:e378.","journal-title":"Oncogenesis"},{"key":"2566_CR99","first-page":"1098","volume":"12","author":"Z Wang","year":"2021","unstructured":"Wang Z, Chen J, Wang M, Zhang L, Yu L. One Stone, Two Birds: The Roles of Tim-3 in Acute Myeloid Leukemia. Front Immunol. 2021;12:1098.","journal-title":"Front Immunol"},{"key":"2566_CR100","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1038\/s41577-019-0224-6","volume":"20","author":"Y Wolf","year":"2020","unstructured":"Wolf Y, Anderson AC, Kuchroo VK. TIM3 comes of age as an inhibitory receptor. Nat Rev Immunol. 2020;20:173\u201385.","journal-title":"Nat Rev Immunol"},{"key":"2566_CR101","doi-asserted-by":"publisher","unstructured":"Zhang H, Liu Z, Gao L, Ma C. Tumor cell-intrinsic Tim-3 promotes liver cancer via NF-\u03baB\/IL-6\/STAT3 axis. 2018. https:\/\/doi.org\/10.1038\/s41388-018-0140-4.","DOI":"10.1038\/s41388-018-0140-4"},{"key":"2566_CR102","doi-asserted-by":"crossref","unstructured":"Cao Y, Zhou X, Huang X, Li Q, Gao L, Jiang L, et al. Tim-3 Expression in Cervical Cancer Promotes Tumor Metastasis. PLoS One. 2013;8:e53834.","DOI":"10.1371\/journal.pone.0053834"},{"key":"2566_CR103","doi-asserted-by":"publisher","first-page":"708","DOI":"10.1016\/j.stem.2010.11.014","volume":"7","author":"Y Kikushige","year":"2010","unstructured":"Kikushige Y, Shima T, Takayanagi SI, Urata S, Miyamoto T, Iwasaki H, et al. TIM-3 is a promising target to selectively kill acute myeloid leukemia stem cells. Cell Stem Cell. 2010;7:708\u201317.","journal-title":"Cell Stem Cell"},{"key":"2566_CR104","doi-asserted-by":"publisher","first-page":"5009","DOI":"10.1073\/pnas.1100551108","volume":"108","author":"M Jan","year":"2011","unstructured":"Jan M, Chao MP, Cha AC, Alizadeh AA, Gentlese AJ, Weissmana IL, et al. Prospective separation of normal and leukemic stem cells based on differential expression of TIM3, a human acute myeloid leukemia stem cell marker. Proc Natl Acad Sci USA. 2011;108:5009\u201314.","journal-title":"Proc Natl Acad Sci USA"},{"key":"2566_CR105","doi-asserted-by":"publisher","first-page":"83","DOI":"10.4103\/ejh.ejh_24_23","volume":"49","author":"HM Atif","year":"2024","unstructured":"Atif HM, Eid IAM. A T-cell receptor as a promising immunotherapeutic target in acute myeloid leukemia: expression of T cell immunoglobulin and mucin-containing-3 on bone marrow hematopoietic cells. Egypt J Haematol. 2024;49:83\u201391.","journal-title":"Egypt J Haematol"},{"key":"2566_CR106","doi-asserted-by":"publisher","first-page":"8956","DOI":"10.1002\/cam4.5549","volume":"12","author":"Z Wu","year":"2023","unstructured":"Wu Z, Ou J, Liu N, Wang Z, Chen J, Cai Z, et al. Upregulation of Tim-3 is associated with poor prognosis in acute myeloid leukemia. Cancer Med. 2023;12:8956\u201369.","journal-title":"Cancer Med"},{"key":"2566_CR107","doi-asserted-by":"publisher","first-page":"244","DOI":"10.1182\/blood-2021-146039","volume":"138","author":"AM Brunner","year":"2021","unstructured":"Brunner AM, Esteve J, Porkka K, Knapper S, Traer E, Scholl S, et al. Efficacy and Safety of Sabatolimab (MBG453) in Combination with Hypomethylating Agents (HMAs) in Patients (Pts) with Very High\/High-Risk Myelodysplastic Syndrome (vHR\/HR-MDS) and Acute Myeloid Leukemia (AML): Final Analysis from a Phase Ib Study. Blood 2021;138:244.","journal-title":"Blood"},{"key":"2566_CR108","first-page":"119","volume":"68","author":"N Guo","year":"2020","unstructured":"Guo N, Zhang K, Gao X, Lv M, Luan J, Hu Z, et al. Role and mechanism of LAIR-1 in the development of autoimmune diseases, tumors, and malaria: A review. Curr Res Transl Med. 2020;68:119\u201324.","journal-title":"Curr Res Transl Med"},{"key":"2566_CR109","doi-asserted-by":"publisher","first-page":"665","DOI":"10.1038\/ncb3158","volume":"17","author":"X Kang","year":"2015","unstructured":"Kang X, Lu Z, Cui C, Deng M, Fan Y, Dong B, et al. The ITIM-containing receptor LAIR1 is essential for acute myeloid leukemia development. Nat Cell Biol. 2015;17:665.","journal-title":"Nat Cell Biol"},{"key":"2566_CR110","doi-asserted-by":"crossref","unstructured":"Lovewell RR, Hong J, Kundu S, Fielder CM, Hu Q, Kim KW, et al. LAIR-1 agonism as a therapy for acute myeloid leukemia. J Clin Invest. 2023;133:e169519.","DOI":"10.1172\/JCI169519"},{"key":"2566_CR111","doi-asserted-by":"crossref","unstructured":"Poggi A, Pellegatta F, Leone BE, Moretta L, Zocchi MR. Engagement of the leukocyte-associated Ig-like receptor-1 induces programmed cell death and prevents NF-kappaB nuclear translocation in human myeloid leukemias. Eur J Immunol. 2000;30:2751\u20138.","DOI":"10.1002\/1521-4141(200010)30:10<2751::AID-IMMU2751>3.0.CO;2-L"},{"key":"2566_CR112","doi-asserted-by":"crossref","unstructured":"Zocchi MR, Pellegatta F, Pierri I, Gobbi M, Poggi A. Leukocyte-associated Ig-like receptor-1 prevents granulocyte-monocyte colony stimulating factor-dependent proliferation and Akt1\/PKB alpha activation in primary acute myeloid leukemia cells. Eur J Immunol. 2001;31:3667\u201375.","DOI":"10.1002\/1521-4141(200112)31:12<3667::AID-IMMU3667>3.0.CO;2-G"},{"key":"2566_CR113","doi-asserted-by":"publisher","first-page":"712632","DOI":"10.3389\/fimmu.2021.712632","volume":"12","author":"Y Shou","year":"2021","unstructured":"Shou Y, Koroleva E, Spencer CM, Shein SA, Korchagina AA, Yusoof KA, et al. Redefining the Role of Lymphotoxin Beta Receptor in the Maintenance of Lymphoid Organs and Immune Cell Homeostasis in Adulthood. Front Immunol. 2021;12:712632.","journal-title":"Front Immunol"},{"key":"2566_CR114","doi-asserted-by":"publisher","first-page":"9617","DOI":"10.1158\/0008-5472.CAN-06-0217","volume":"66","author":"M Lukashev","year":"2006","unstructured":"Lukashev M, LePage D, Wilson C, Bailly V, Garber E, Lukashin A, et al. Targeting the Lymphotoxin-\u03b2 Receptor with Agonist Antibodies as a Potential Cancer Therapy. Cancer Res. 2006;66:9617\u201324.","journal-title":"Cancer Res"},{"key":"2566_CR115","doi-asserted-by":"crossref","first-page":"1","DOI":"10.36080\/comm.v12i1.1328","volume":"12","author":"SS H\u00f6pner","year":"2021","unstructured":"H\u00f6pner SS, Raykova A, Radpour R, Amrein MA, Koller D, Baerlocher GM, et al. LIGHT\/LT\u03b2R signaling regulates self-renewal and differentiation of hematopoietic and leukemia stem cells. Nature. Communications. 2021;12:1\u201316.","journal-title":"Communications"},{"key":"2566_CR116","doi-asserted-by":"publisher","first-page":"111178","DOI":"10.1016\/j.intimp.2023.111178","volume":"125","author":"XP Li","year":"2023","unstructured":"Li XP, Dai Y, Zhang WN, Pan MM, Mao J, Zhao B, et al. Single-cell RNA-seq reveals novel immune-associated biomarkers for predicting prognosis in AML patients with RUNX1::RUNX1T1. Int Immunopharmacol. 2023;125:111178.","journal-title":"Int Immunopharmacol"},{"key":"2566_CR117","doi-asserted-by":"publisher","first-page":"5956","DOI":"10.1182\/blood-2023-180914","volume":"142","author":"S Hoepner","year":"2023","unstructured":"Hoepner S, Delahaye T, Riether C, Ochsenbein A. Monoclonal Antibodies Targeting LIGHT Block Ltbr Signalling and Eliminate Acute Myeloid Leukemia Stem Cells. Blood 2023;142:5956.","journal-title":"Blood"},{"key":"2566_CR118","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13046-021-02215-y","volume":"41","author":"T Flieswasser","year":"2022","unstructured":"Flieswasser T, Van den Eynde A, Van Audenaerde J, De Waele J, Lardon F, Riether C, et al. The CD70-CD27 axis in oncology: the new kids on the block. J Exp Clin Cancer Res. 2022;41:1\u201315.","journal-title":"J Exp Clin Cancer Res"},{"key":"2566_CR119","doi-asserted-by":"publisher","first-page":"3901","DOI":"10.4049\/jimmunol.173.6.3901","volume":"173","author":"R Arens","year":"2004","unstructured":"Arens R, Nolte MA, Tesselaar K, Heemskerk B, Reedquist KA, van Lier RAW, et al. Signaling through CD70 regulates B cell activation and IgG production. J Immunol. 2004;173:3901\u20138.","journal-title":"J Immunol"},{"key":"2566_CR120","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1189\/jlb.1003508","volume":"76","author":"P Garc\u00eda","year":"2004","unstructured":"Garc\u00eda P, de Heredia AB, Bell\u00f3n T, Carpio E, Llano M, Caparr\u00f3s E, et al. Signalling via CD70, a member of the TNF family, regulates T cell functions. J Leukoc Biol. 2004;76:263\u201370.","journal-title":"J Leukoc Biol"},{"key":"2566_CR121","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1182\/blood-2016-12-756585","volume":"130","author":"MF Al Sayed","year":"2017","unstructured":"Al Sayed MF, Ruckstuhl CA, Hilmenyuk T, Claus C, Bourquin JP, Bornhauser BC, et al. CD70 reverse signaling enhances NK cell function and immunosurveillance in CD27-expressing B-cell malignancies. Blood. 2017;130:297\u2013309.","journal-title":"Blood."},{"key":"2566_CR122","doi-asserted-by":"publisher","first-page":"412","DOI":"10.1038\/ni1174","volume":"6","author":"MA Nolte","year":"2005","unstructured":"Nolte MA, Arens R, Van Os R, Van Oosterwijk M, Hooibrink B, Van Lier RAW, et al. Immune activation modulates hematopoiesis through interactions between CD27 and CD70. Nat Immunol. 2005;6:412\u20138.","journal-title":"Nat Immunol"},{"key":"2566_CR123","doi-asserted-by":"publisher","first-page":"624","DOI":"10.1172\/JCI45977","volume":"122","author":"C Sch\u00fcrch","year":"2012","unstructured":"Sch\u00fcrch C, Riether C, Matter MS, Tzankov A, Ochsenbein AF. CD27 signaling on chronic myelogenous leukemia stem cells activates Wnt target genes and promotes disease progression. J Clin Invest. 2012;122:624.","journal-title":"J Clin Invest"},{"key":"2566_CR124","doi-asserted-by":"crossref","unstructured":"Riether C, Sch\u00fcrch CM, Flury C, Hinterbrandner M, Dr\u00fcck L, Huguenin AL, et al. Tyrosine kinase inhibitor-induced CD70 expression mediates drug resistance in leukemia stem cells by activating Wnt signaling. Sci Transl Med. 2015;7:298ra119.","DOI":"10.1126\/scitranslmed.aab1740"},{"key":"2566_CR125","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1084\/jem.20152008","volume":"214","author":"C Riether","year":"2017","unstructured":"Riether C, Sch\u00fcrch CM, B\u00fchrer ED, Hinterbrandner M, Huguenin A-L, Hoepner S, et al. CD70\/CD27 signaling promotes blast stemness and is a viable therapeutic target in acute myeloid leukemia. J Exp Med. 2017;214:359\u201380.","journal-title":"J Exp Med"},{"key":"2566_CR126","doi-asserted-by":"publisher","first-page":"1459","DOI":"10.1038\/s41591-020-0910-8","volume":"26","author":"C Riether","year":"2020","unstructured":"Riether C, Pabst T, H\u00f6pner S, Bacher U, Hinterbrandner M, Banz Y, et al. Targeting CD70 with cusatuzumab eliminates acute myeloid leukemia stem cells in patients treated with hypomethylating agents. Nat Med. 2020;26:1459\u201367. 2020 26:9","journal-title":"Nat Med"},{"key":"2566_CR127","doi-asserted-by":"publisher","first-page":"1793","DOI":"10.3324\/haematol.2022.281563","volume":"108","author":"T Pabst","year":"2023","unstructured":"Pabst T, Vey N, Ad\u00e8s L, Bacher U, Bargetzi M, Fung S, et al. Results from a phase I\/II trial of cusatuzumab combined with azacitidine in patients with newly diagnosed acute myeloid leukemia who are ineligible for intensive chemotherapy. Haematologica. 2023;108:1793.","journal-title":"Haematologica."},{"key":"2566_CR128","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1182\/blood-2021-150371","volume":"138","author":"GJ Roboz","year":"2021","unstructured":"Roboz GJ, Pabst T, Aribi A, Brandwein JM, D\u00f6hner H, Fiedler W, et al. Safety and Efficacy of Cusatuzumab in Combination with Venetoclax and Azacitidine (CVA) in Patients with Previously Untreated Acute Myeloid Leukemia (AML) Who Are Not Eligible for Intensive Chemotherapy; An Open-Label, Multicenter, Phase 1b Study. Blood. 2021;138:369.","journal-title":"Blood."},{"key":"2566_CR129","doi-asserted-by":"publisher","first-page":"521907","DOI":"10.3389\/fonc.2020.00827","volume":"10","author":"M Kampa","year":"2020","unstructured":"Kampa M, Notas G, Stathopoulos EN, Tsapis A, Castanas E. The TNFSF Members APRIL and BAFF and Their Receptors TACI, BCMA, and BAFFR in Oncology, With a Special Focus in Breast Cancer. Front Oncol. 2020;10:521907.","journal-title":"Front Oncol"},{"key":"2566_CR130","doi-asserted-by":"publisher","first-page":"4748","DOI":"10.4049\/jimmunol.1102891","volume":"189","author":"G Notas","year":"2012","unstructured":"Notas G, Alexaki V-I, Kampa M, Pelekanou V, Charalampopoulos I, Sabour-Alaoui S, et al. APRIL Binding to BCMA Activates a JNK2\u2013FOXO3\u2013GADD45 Pathway and Induces a G2\/M Cell Growth Arrest in Liver Cells. J Immunol. 2012;189:4748\u201358.","journal-title":"J Immunol"},{"key":"2566_CR131","doi-asserted-by":"publisher","first-page":"83250","DOI":"10.1371\/journal.pone.0083250","volume":"8","author":"V Pelekanou","year":"2013","unstructured":"Pelekanou V, Notas G, Kampa M, Tsentelierou E, Stathopoulos EN, Tsapis A, et al. BAFF, APRIL, TWEAK, BCMA, TACI and Fn14 Proteins Are Related to Human Glioma Tumor Grade: Immunohistochemistry and Public Microarray Data Meta-Analysis. PLoS One. 2013;8:83250.","journal-title":"PLoS One"},{"key":"2566_CR132","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41408-020-0337-y","volume":"10","author":"A Dogan","year":"2020","unstructured":"Dogan A, Siegel D, Tran N, Fu A, Fowler J, Belani R, et al. B-cell maturation antigen expression across hematologic cancers: a systematic literature review. Blood Cancer J. 2020;10:1\u201313.","journal-title":"Blood Cancer J"},{"key":"2566_CR133","doi-asserted-by":"publisher","first-page":"1979","DOI":"10.7150\/jca.15966","volume":"7","author":"L Bolkun","year":"2016","unstructured":"Bolkun L, Grubczak K, Schneider G, Zembko P, Radzikowska U, Singh P, et al. Involvement of BAFF and APRIL in Resistance to Apoptosis of Acute Myeloid Leukemia. J Cancer. 2016;7:1979.","journal-title":"J Cancer"},{"key":"2566_CR134","doi-asserted-by":"publisher","first-page":"2006","DOI":"10.3324\/haematol.2018.192062","volume":"104","author":"M Chapellier","year":"2019","unstructured":"Chapellier M, Pe\u00f1a-Mart\u00ednez P, Ramakrishnan R, Eriksson M, Talkhoncheh MS, Orsmark-Pietras C, et al. Arrayed molecular barcoding identifies TNFSF13 as a positive regulator of acute myeloid leukemia-initiating cells. Haematologica. 2019;104:2006.","journal-title":"Haematologica."},{"key":"2566_CR135","doi-asserted-by":"publisher","first-page":"1899","DOI":"10.3324\/haematol.13035","volume":"93","author":"D Bonci","year":"2008","unstructured":"Bonci D, Musumeci M, Coppola V, Addario A, Conticello C, Hahne M, et al. Blocking the APRIL circuit enhances acute myeloid leukemia cell chemosensitivity. Haematologica. 2008;93:1899\u2013902.","journal-title":"Haematologica."},{"key":"2566_CR136","doi-asserted-by":"crossref","unstructured":"Wu G, Guo S, Luo Q, Wang X, Deng W, Ouyang G, et al. Preclinical evaluation of CD70-specific CAR T cells targeting acute myeloid leukemia. Front Immunol. 2023;14:1093750.","DOI":"10.3389\/fimmu.2023.1093750"},{"key":"2566_CR137","doi-asserted-by":"publisher","first-page":"S178","DOI":"10.1016\/j.jtct.2023.12.232","volume":"30","author":"JA Ligon","year":"2024","unstructured":"Ligon JA, Castillo P, Ma X, Jin L, Tao H, Nguyen D, et al. CD70 CXCR2-Modified CAR T-Cells Against Acute Myeloid Leukemia. Transpl Cell Ther. 2024;30:S178\u20139.","journal-title":"Transpl Cell Ther"},{"key":"2566_CR138","doi-asserted-by":"publisher","first-page":"318","DOI":"10.1182\/blood.2020008221","volume":"138","author":"T Sauer","year":"2021","unstructured":"Sauer T, Parikh K, Sharma S, Omer B, Sedloev D, Chen Q, et al. CD70-specific CAR T cells have potent activity against acute myeloid leukemia without HSC toxicity. Blood. 2021;138:318\u201330.","journal-title":"Blood."}],"container-title":["Leukemia"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41375-025-02566-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41375-025-02566-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41375-025-02566-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,3]],"date-time":"2025-06-03T08:03:20Z","timestamp":1748937800000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41375-025-02566-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4,2]]},"references-count":138,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2025,6]]}},"alternative-id":["2566"],"URL":"https:\/\/doi.org\/10.1038\/s41375-025-02566-x","relation":{},"ISSN":["0887-6924","1476-5551"],"issn-type":[{"value":"0887-6924","type":"print"},{"value":"1476-5551","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,4,2]]},"assertion":[{"value":"21 November 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 February 2025","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 March 2025","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 April 2025","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}